Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2

Status

Completed 3Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 28Plasma cell 13Other hematologic neoplasm 12Myeloid 8Thoracic 6Genitourinary 6CNS 6Tumor-Agnostic 5Sarcoma 5Dermatologic 4Classical hematology 4Breast 4Lymphoid 3Other 2Gynecologic 2Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 2Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Ascorbic Acid × Thoracic × Clear all
NCT02905591 2026-03-25

XACT-LUNG

University of Iowa

Phase 2 Active not recruiting
43 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05849129 2026-01-23

AIVAA

The Canadian College of Naturopathic Medicine

Phase 2 Recruiting
90 enrolled
Thoracic

Lung Neoplasms

NCT02420314 2024-08-20

Pharmacological Ascorbate for Lung Cancer

University of Iowa

Phase 2 Completed
55 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03146962 2024-05-02

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

Weill Medical College of Cornell University

Phase 2 Completed
61 enrolled 24 charts
GastrointestinalThoracic

Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03799094 2019-01-10

Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

Clifford Hospital, Guangzhou, China

Phase 1/2 Unknown
150 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02655913 2018-11-30

VCONSCLC

Clifford Hospital, Guangzhou, China

Phase 1/2 Completed
97 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡